Company / Depreciation & Amortization
TherapeuticsMD, Inc. Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$922.0K
FY2024
5-year range
$293.9K / $1.4M
FY2020-FY2024
Trend
-22.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $52,467 in FY2016 to $1M in FY2021.
Based on SEC 10-K filings.
$922,000 in FY2024 with a 5-year CAGR of +34.0%.
Increased from $736,000 to $922,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -12.8%
- 5-Year CAGR
- +34.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +34.0%, indicating consistent growth.
- In FY2024, depreciation & amortization decreased 22.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2021.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $922.0K | -22.7% |
| FY2023 | $1.2M | +62.1% |
| FY2022 | $736.0K | -47.1% |
| FY2021 | $1.4M | +373.7% |
| FY2020 | $293.9K | +37.9% |
| FY2019 | $213.1K | +60.9% |
| FY2018 | $132.5K | +112.3% |
| FY2017 | $62.4K | +18.9% |
| FY2016 | $52.5K | -9.8% |
| FY2015 | $58.1K | +3.4% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026